STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBDDan Turner, Axel Dignaß, Amanda Ricciuto et al.|Gastroenterology|2021Cited by 2.6k
Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47Carl A. Anderson, Craig Mowat, Marla C. Dubinsky et al.|Nature Genetics|2011Cited by 1.4k
Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International RegistryErica J. Brenner, Michael D. Kappelman, Ryan C. Ungaro et al.|Gastroenterology|2020Cited by 692
Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and RORγt+ Regulatory T Cells and Exacerbate Colitis in MiceGraham J. Britton, Jeremiah J. Faith, Eduardo J. Contijoch et al.|Immunity|2019Cited by 553
Intestinal Host Response to SARS-CoV-2 Infection and COVID-19 Outcomes in Patients With Gastrointestinal SymptomsAlexandra E. Livanos, Francesca Petralia, Saurabh Mehandru et al.|Gastroenterology|2021Cited by 160